U.S. FDA issues temporary halt to ban on Juul e-cigarettes

The U.S. Meals and Drug Administration (FDA) has placed on maintain its ban on gross sales of Juul Labs’ e-cigarettes, with the well being company saying late on Tuesday that it might do an extra evaluation of the corporate’s advertising and marketing utility.

Juul had gained a short lived reprieve a few weeks in the past after a U.S. federal appeals courtroom stayed the FDA’s ban, following an attraction from the corporate for an emergency evaluation of the regulator’s order.

The as soon as red-hot vape firm has said the FDA’s choice to dam gross sales of its merchandise is “extraordinary and illegal,” citing, amongst different issues, the company’s authorization of comparable e-cigarette merchandise made by different producers.

In a sequence of tweets on Tuesday, the FDA said there have been “scientific points distinctive to the Juul utility that warrant extra evaluation.”

“The keep and the company’s evaluation doesn’t represent authorization to market, promote or ship JUUL merchandise,” the company added.

Whereas imposing its ban on June 23, the FDA said Juul had failed to indicate the sale of its merchandise can be acceptable for public well being, following a virtually two-year evaluation of information supplied by the corporate.

“(The newest) announcement by the FDA would recommend that it concedes information had been ignored and a chance they obtained their choice fallacious,” wrote analysts with monetary providers agency Jefferies in a word.

Juul, partly owned by tobacco big Altria Group, didn’t reply to a Reuters request for remark.

The corporate is more likely to spend little time, if any in any respect, off the market, because it now has extra time to amend its utility or present extra information if essential, Jefferies said.